"Diabetic Angiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Descriptor ID |
D003925
|
MeSH Number(s) |
C14.907.320 C19.246.099.500
|
Concept/Terms |
Diabetic Angiopathies- Diabetic Angiopathies
- Angiopathies, Diabetic
- Angiopathy, Diabetic
- Diabetic Angiopathy
- Diabetic Vascular Diseases
- Diabetic Vascular Disease
- Vascular Disease, Diabetic
- Vascular Diseases, Diabetic
- Diabetic Vascular Complications
- Diabetic Vascular Complication
- Vascular Complication, Diabetic
- Vascular Complications, Diabetic
Microangiopathy, Diabetic- Microangiopathy, Diabetic
- Diabetic Microangiopathies
- Diabetic Microangiopathy
- Microangiopathies, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Angiopathies".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Angiopathies".
This graph shows the total number of publications written about "Diabetic Angiopathies" by people in this website by year, and whether "Diabetic Angiopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 1 | 1 | 2 |
1996 | 2 | 2 | 4 |
1997 | 4 | 2 | 6 |
1998 | 1 | 2 | 3 |
1999 | 3 | 0 | 3 |
2002 | 5 | 0 | 5 |
2003 | 5 | 1 | 6 |
2004 | 3 | 2 | 5 |
2005 | 5 | 1 | 6 |
2006 | 2 | 2 | 4 |
2007 | 2 | 0 | 2 |
2008 | 6 | 5 | 11 |
2009 | 0 | 1 | 1 |
2010 | 2 | 2 | 4 |
2011 | 3 | 3 | 6 |
2012 | 1 | 0 | 1 |
2013 | 6 | 0 | 6 |
2014 | 4 | 0 | 4 |
2015 | 6 | 1 | 7 |
2016 | 3 | 0 | 3 |
2017 | 4 | 1 | 5 |
2018 | 2 | 0 | 2 |
2019 | 1 | 1 | 2 |
2020 | 2 | 2 | 4 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Angiopathies" by people in Profiles.
-
Glycemic Variability, Glycated Hemoglobin, and Cardiovascular Complications: Still a Dilemma in Clinical Practice. Adv Ther. 2022 01; 39(1):1-4.
-
Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study. J Clin Endocrinol Metab. 2020 10 01; 105(10).
-
Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register. Diabetes Care. 2020 09; 43(9):2257-2265.
-
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020 07; 52(7):680-691.
-
Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2020 04; 43(4):867-874.
-
Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort. J Diabetes Complications. 2019 10; 33(10):107410.
-
Burden of Cardiovascular Risk Factors Over Time and Arterial Stiffness in Youth With Type 1 Diabetes Mellitus: The SEARCH for?Diabetes in Youth Study. J Am Heart Assoc. 2019 07 02; 8(13):e010150.
-
Challenges in vascular tissue engineering for diabetic patients. Acta Biomater. 2018 04 01; 70:25-34.
-
Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus. Arterioscler Thromb Vasc Biol. 2018 03; 38(3):529-541.
-
Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk. J Diabetes Complications. 2018 02; 32(2):210-215.